![Joelle Permut](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Joelle Permut currently works at BabyCare Ltd., as Manager-Human Resources.
Aktive Positionen von Joelle Permut
Unternehmen | Position | Beginn |
---|---|---|
BabyCare Ltd.
![]() BabyCare Ltd. Pharmaceuticals: MajorHealth Technology BabyCare operates 20 centers in 16 cities and plans to expand to eight more cities in 2006. BabyCare is the brainchild of Matthew J. Estes, a 39-year-old San Diego native who has lived and worked in China for 15 years, part of that time as a sales manager for pharmaceutical maker SmithKline Beecham, now GlaxoSmithKline PLC (GSK ). He founded BabyCare to exploit what he saw as a big potential market in China for nutritional supplements for expectant mothers and infants. BabyCare's rapid growth has, predictably, attracted venture capitalists. The company has raised a total of $24 million in three rounds of funding since it began. Investors include Silicon Valley VC fund Sutter Hill Ventures, and Hong Kong's Pacific Group. | Personalreferent | 10.11.2009 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
BabyCare Ltd.
![]() BabyCare Ltd. Pharmaceuticals: MajorHealth Technology BabyCare operates 20 centers in 16 cities and plans to expand to eight more cities in 2006. BabyCare is the brainchild of Matthew J. Estes, a 39-year-old San Diego native who has lived and worked in China for 15 years, part of that time as a sales manager for pharmaceutical maker SmithKline Beecham, now GlaxoSmithKline PLC (GSK ). He founded BabyCare to exploit what he saw as a big potential market in China for nutritional supplements for expectant mothers and infants. BabyCare's rapid growth has, predictably, attracted venture capitalists. The company has raised a total of $24 million in three rounds of funding since it began. Investors include Silicon Valley VC fund Sutter Hill Ventures, and Hong Kong's Pacific Group. | Health Technology |